Home Applications 125288 Application 125288
Type BLA
Sponsor BRISTOL MYERS SQUIBB Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125288 Nulojix belatacept 351(a) Rx 2026-07-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 NULOJIX BELATACEPT INJECTABLE; INJECTION 250MG No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join NULOJIX BELATACEPT E.R. Squibb & Sons, L.L.C. c16ac648-d5d2-9f7d-8637-e2328572754e 2021-07-28 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA125288 ndc (product): 0003-0371
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 5 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0003-0371 NULOJIX BELATACEPT E.R. Squibb & Sons, L.L.C. BLA Current 0003-0371 NULOJIX BELATACEPT E.R. Squibb & Sons, L.L.C. BLA Current 0003-0371 NULOJIX BELATACEPT E.R. Squibb & Sons, L.L.C. BLA Current 0003-0371 NULOJIX BELATACEPT E.R. Squibb & Sons, L.L.C. BLA Current 0003-0371 NULOJIX BELATACEPT E.R. Squibb & Sons, L.L.C. BLA Current